Physician profile
Alexander C Whitley
NPI 1063648509
$440,627.72
in general payments reported to CMS, 2019-2025
19 companies · $67K in 2025
The $67K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $106K · 2021: $45K · 2022: $32K · 2023: $64K · 2024: $65K · 2025: $67K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $85K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83K · Travel and Lodging: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,075 · Food and Beverage: $3,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,482.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83,105.00 |
| Travel and Lodging | $15,389.59 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,075.00 |
| Food and Beverage | $3,387.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $326,075.16 | 2019-2025 | Imfinzi, Tagrisso |
| Novocure INC. | $84,906.33 | 2019-2025 | Optune, Optune Gio |
| Novocure Gmbh | $15,750.00 | 2023 | Optune |
| Siemens Medical Solutions USA, INC. | $11,996.96 | 2019-2023 | Halcyon, Truebeam, Bravos Afterloader System |
| Boston Scientific Corporation | $335.36 | 2019 | |
| Novartis Pharmaceuticals Corporation | $271.88 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.95 | 2021-2025 | Libtayo |
| Visionrt, INC. | $199.47 | 2019 | |
| Sumitomo Pharma America, INC. | $184.87 | 2023-2025 | Orgovyx |
| Viewray Technologies INC | $160.27 | 2019 | |
| Myovant Sciences INC. | $143.24 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.81 | 2019-2025 | |
| Varian Medical Systems, INC. | $71.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $59.80 | 2019 | |
| Blue Earth Diagnostics | $59.32 | 2021-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $35.36 | 2022 | |
| Tactile Systems Technology INC | $31.06 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Eisai INC. | $12.99 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Whitley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.